在新诊断的急性髓性白血病患者中，我如何管理维尼托克拉克斯和阿扎胞苷的髓毒性?

{"title":"在新诊断的急性髓性白血病患者中，我如何管理维尼托克拉克斯和阿扎胞苷的髓毒性?","authors":"Aleksander Salomon-Perzyński, B. Budziszewska","doi":"10.5603/hcp.2023.0002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":284891,"journal":{"name":"Hematology in Clinical Practice","volume":"43 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How do I manage the myelotoxicity of venetoclax and azacitidine in patients with newly diagnosed acute myeloid leukemia?\",\"authors\":\"Aleksander Salomon-Perzyński, B. Budziszewska\",\"doi\":\"10.5603/hcp.2023.0002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":284891,\"journal\":{\"name\":\"Hematology in Clinical Practice\",\"volume\":\"43 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hematology in Clinical Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/hcp.2023.0002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology in Clinical Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/hcp.2023.0002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}